Does obesity increase left ventricular mass and worsen heart failure symptoms in patients with hypertrophic cardiomyopathy?
Obesity in hypertrophic cardiomyopathy is independently associated with greater left ventricular hypertrophy and a higher risk of developing severe heart failure symptoms.
Obesity and its association to phenotype and clinical course in hypertrophic cardiomyopathy Olivotto I. ; Maron B. J.; Tomberli B. ; Appelbaum E.; Salton C.; Haas T. S.; Gibson C. M.; Nistri S. ; SERVETTINI, ELEONORA ; Chan R. H.; Udelson J. E.; Lesser J. R.; Cecchi F. ; Manning W. J.; Maron M. S. 2013 Abstract This study sought to assess the impact of body mass index (BMI) on cardiac phenotypic and clinical course in a multicenter hypertrophic cardiomyopathy (HCM) cohort. At multivariate analysis, BMI proved independently associated with the magnitude of hypertrophy: pre-obese and obese HCM patients (BMI 25 to 30 kg/m2 and >30 kg/m2 , respectively) showed a 65% and 310% increased likelihood of an LV mass in the highest quartile (>120 g/m2 ), compared with normal weight patients (BMI 120 g/m2 were LV outflow obstruction (HR: 4.9; 95% CI: 2.4 to 9.8; p < 0.001), systemic hypertension (HR: 2.2; 95% CI: 1.1 to 4.5; p ¼ 0.026), and male sex (HR: 2.1; 95% CI: 0.9 to 4.7; p ¼ 0.083). During a median follow-up of 3.7 years (interquartile range: 2.5 to 5.3), obese patients showed an HR of 3.6 (95% CI: 1.2 to 10.7, p ¼ 0.02) for developing New York Heart Association (NYHA) functional class III to IV symptoms compared to nonobese patients, independent of outflow obstruction. Noticeably, the proportion of patients in NYHA functional class III at the end of follow-up was 13% among obese patients, compared with 6% among those of normal weight (p ¼ 0.03).
Olivotto et al. (Tue,) studied this question.